Triple‐negative breast cancer (TNBC), defined by lacking oestrogen receptor (ER), progesterone receptor (PR), and HER2 (Human Epidermal Growth Factor Receptor 2) expression, represents the most aggressive subtype of breast cancer. This evidence concerns the gene ERBB2 and breast cancer.